Heavey A M, Philpot M P, Fensom A H, Jackson M, Crammer J L
Department of Psychiatry, Institute of Psychiatry, Guy's Hospital, London, United Kingdom.
Acta Psychiatr Scand. 1990 Jul;82(1):55-9. doi: 10.1111/j.1600-0447.1990.tb01355.x.
Previous studies have suggested that arylsulphatase A (ASA - the biochemical marker of metachromatic leucodystrophy) deficiency may be present in a sizeable proportion of patients with chronic psychosis. This study surveyed leucocyte ASA activity in a group of chronic psychotic patients and compared ASA activity in 3 subgroups fulfilling Research Diagnostic Criteria for schizophrenia (undifferentiated), paranoid schizophrenia and schizoaffective psychosis. Three of 45 patients had significantly reduced ASA activity but none had metachromatic leucodystrophy. Although ASA levels did not differ significantly between the groups, schizophrenics without a family history of schizophrenia had significantly lower ASA levels than those with. The implications of these findings are discussed.
以往的研究表明,慢性精神病患者中相当一部分可能存在芳基硫酸酯酶A(ASA——异染性脑白质营养不良的生化标志物)缺乏。本研究调查了一组慢性精神病患者的白细胞ASA活性,并比较了符合精神分裂症研究诊断标准(未分化型)、偏执型精神分裂症和分裂情感性精神病的3个亚组的ASA活性。45名患者中有3名的ASA活性显著降低,但无人患有异染性脑白质营养不良。尽管各组之间的ASA水平无显著差异,但无精神分裂症家族史的精神分裂症患者的ASA水平显著低于有家族史的患者。对这些发现的意义进行了讨论。